Manuscripts
Showing 1543 manuscripts.
Infrequent Detection of Hiv-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Celll Responses in Young HIV-1-Infected Infants.
Citation
Z. A. Scott, Ellen Gould Chadwick, Lynn Gibson, Margaret McManus, Ram Yogev, Paul Palumbo, John L. Sullivan, Paula Britto, Hannah Gay, Katherine Luzuriaga. Infrequent Detection of Hiv-1-Specific, But Not Cytomegalovirus-Specific, CD8+ T Celll Responses in Young HIV-1-Infected Infants.. Journal of Immunology. 2001. 167: 7134-7140.Year
2001
Journal
Journal of Immunology
Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy
Citation
Nancy S. Shulman, Roderick A. Machekano, Robert Shafer, Mark A. Winters, Andrew R. Zolopa, Song-Heng Liou, Michael Hughes, David Katzenstein. Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy. Journal of Acquired Immune Deficiency Syndromes. 2001. 27: 377-80.Year
2001
Journal
Journal of Acquired Immune Deficiency Syndromes
DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS
Citation
Ann Le Monte, Mitchell (Mitch) Goldman, Melinda L. Smedema, Patricia A. Connolly, David S. McKinsey, Gretchen Cloud, Carol Kauffman, L. Joseph Wheat. DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS. Medical Mycology. 2001. 39: 207-13.Year
2001
Journal
Medical Mycology
Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999
Citation
Hernan Valdez, Tanvir K. Chowdhry, Robert Asaad, Ian Woolley, Traci L. Davis, Robin Davidson, Nele K. Beinker, Barbara Gripshover, Robert A. Salata, Grace McComsey, Sharon Weissman, Michael M. Lederman. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995--1999. Clinical Infectious Diseases. 2001. 32: 1487-93.Year
2001
Journal
Clinical Infectious Diseases
High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients
Citation
Robert Shafer, Kurt Hertogs, Andrew R. Zolopa, Ann Warford, Stuart Bloor, Bradley J. Betts, Thomas C. Merigan, Richard Harrigan, Brendan Larder. High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease and reverse transcriptase sequencing of plasma samples from heavily treated patients. Journal of Clinical Microbiology. 2001. 39: 1522-9.Year
2001
Journal
Journal of Clinical Microbiology
Methods for conducting sensitivity analysis of trials with potentially nonignorable competing causes of censoring
Citation
A. Rotnitzky, D. Scharfstein, T. L. Su, J. Robins. Methods for conducting sensitivity analysis of trials with potentially nonignorable competing causes of censoring. Biometrics. 2001. 57: 103-13.Year
2001
Journal
Biometrics
Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.
Citation
Robert W. Coombs, David Wright, Patricia Reichelderfer, David Burns, Jonathan Cohn, Susan Cu-Uvin, Penny Baron, Morty Cohen, Alan Landay, S. Lewis, Andrea Kovacs. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women.. Journal of Infectious Diseases. 2001. 184: 1187-91.Year
2001
Journal
Journal of Infectious Diseases
Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance.
Citation
Jing Lu, Jean-Michel Gries, Davide Verotta, Lewis Sheiner. Selecting reliable pharmacokinetic data for explanatory analyses of clinical trials in the presence of possible noncompliance.. Journal of Pharmacokinetics & Pharmacodynamics (prev. Journal of Pharmacokinetics and Biopharmaceutics). 2001. 28: 343-62.Year
2001
Journal
Journal of Pharmacokinetics & Pharmacodynamics (prev. Journal of Pharmacokinetics and Biopharmaceutics)
Lymphoproliferative Responses To Recombinant HIV-1 Envelope Antigens In Neonates and Infants Receiving GP 120 Vaccines
Citation
William Borkowsky, Diane W. Wara, Terence Fenton, James McNamara, Minhee Kang, Lynne M. Mofenson, Elizabeth (Betsy) J. McFarland, Coleen K. Cunningham, Anne-Marie Duliege, Donald P. Francis, Yvonne J. Bryson, Sandra K. Burchett, Stephen A. Spector, Lisa M. Frenkel, Stuart E. Starr, Russell B. Van Dyke, Eleanor Jimenez. Lymphoproliferative Responses To Recombinant HIV-1 Envelope Antigens In Neonates and Infants Receiving GP 120 Vaccines. Journal of Infectious Diseases. 2000. 181: 890-6.Year
2000
Journal
Journal of Infectious Diseases
Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts.
Citation
James McNamara, George D. McSherry, Kenneth McIntosh, Wendy G Mitchell, Marc Bulterys, Lynne M. Mofenson, Sandra K. Burchett, James M. Oleske, Mary Culnane, P. H. Rhodes, Bethann Cunningham-Schrader, David E. Shapiro, Ken Dominguez, Elizabeth (Betsy) Smith, Lisa M. Dunkle, B. Styrt, Linda Draper (Marillo), Linda Draper (Marillo), Mary Glenn Fowler, I. Celine Hanson, E. Kpamegan, Mary Lou Lindegren, J. Louise Martin-Carpenter. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts.. Journal of Acquired Immune Deficiency Syndromes. 2000. 25: 261-268.Year
2000
Journal
Journal of Acquired Immune Deficiency Syndromes